[{"orgOrder":0,"company":"ProofPilot","sponsor":"Noho Health","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Phase III","graph3":"ProofPilot","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"ProofPilot \/ Noho Health","highestDevelopmentStatusID":"10","companyTruncated":"ProofPilot \/ Noho Health"},{"orgOrder":0,"company":"Vascudyne, Inc.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Nephrology","graph2":"Phase I","graph3":"Vascudyne, Inc.","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Implant","sponsorNew":"Vascudyne, Inc. \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Vascudyne, Inc. \/ Inapplicable"},{"orgOrder":0,"company":"Cayman Chemical Company Inc","sponsor":"NIDCR","pharmaFlowCategory":"D","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Other Small Molecule","year":"2021","type":"Funding","leadProduct":"Collagen","moa":"||Undisclosed","graph1":"Musculoskeletal","graph2":"Preclinical","graph3":"Cayman Chemical Company Inc","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Dental Implant","sponsorNew":"Cayman Chemical Company Inc \/ NIDCR","highestDevelopmentStatusID":"4","companyTruncated":"Cayman Chemical Company Inc \/ NIDCR"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"SPAIN","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Hyaluronic Acid","moa":"||Collagen synthesis","graph1":"Dermatology","graph2":"Preclinical","graph3":"Bioiberica","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bioiberica \/ Inapplicable","highestDevelopmentStatusID":"4","companyTruncated":"Bioiberica \/ Inapplicable"},{"orgOrder":0,"company":"ProofPilot","sponsor":"Qina","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"ProofPilot","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"ProofPilot \/ Qina","highestDevelopmentStatusID":"1","companyTruncated":"ProofPilot \/ Qina"},{"orgOrder":0,"company":"PepsiCo","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"PepsiCo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PepsiCo \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"PepsiCo \/ Inapplicable"},{"orgOrder":0,"company":"Vinh Hoan Corporation","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Vinh Hoan Corporation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vinh Hoan Corporation \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"Vinh Hoan Corporation \/ KGK Science"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"VIST","sponsor":"Tosla d.o.o. | Slovenian Research Agency","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"VIST","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VIST \/ Tosla d.o.o. | Slovenian Research Agency","highestDevelopmentStatusID":"1","companyTruncated":"VIST \/ Tosla d.o.o. | Slovenian Research Agency"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Sleep","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ BioTeSys GmbH"},{"orgOrder":0,"company":"NovoBliss Research","sponsor":"Collagen Lifesciences Private Limited","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"NovoBliss Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NovoBliss Research \/ Collagen Lifesciences Private Limited","highestDevelopmentStatusID":"1","companyTruncated":"NovoBliss Research \/ Collagen Lifesciences Private Limited"},{"orgOrder":0,"company":"Florida State University","sponsor":"Tessenderlo Chemie NV","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Protein","year":"2023","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Neurology","graph2":"Undisclosed","graph3":"Florida State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Florida State University \/ Tessenderlo Chemie NV","highestDevelopmentStatusID":"1","companyTruncated":"Florida State University \/ Tessenderlo Chemie NV"},{"orgOrder":0,"company":"Tiss'You srl","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"","productType":"Protein","year":"2023","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Tiss'You srl","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Injection","sponsorNew":"Tiss'You srl \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Tiss'You srl \/ Inapplicable"},{"orgOrder":0,"company":"Simply Plus Co., Ltd.","sponsor":"Chia Nan University of Pharmacy and Science","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Protein","year":"2025","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Simply Plus Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Simply Plus Co., Ltd. \/ Chia Nan University of Pharmacy and Science","highestDevelopmentStatusID":"1","companyTruncated":"Simply Plus Co., Ltd. \/ Chia Nan University of Pharmacy and Science"}]

Find Clinical Drug Pipeline Developments & Deals for Collagen

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate

                          Therapeutic Area : Dermatology

                          Study Phase : Preclinical

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.

                          Product Name : Dermial

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 25, 2022

                          Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate

                          Therapeutic Area : Dermatology

                          Highest Development Status : Preclinical

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Bioiberica Company Banner

                          02

                          Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Undisclosed

                          September 16, 2021

                          Lead Product(s) : KMN-159,Collagen

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Preclinical

                          Sponsor : NIDCR

                          Deal Size : $1.7 million

                          Deal Type : Funding

                          Cayman

                          03

                          Simply Plus Co., Ltd.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Simply Plus Co., Ltd.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          March 28, 2025

                          Lead Product(s) : Collagen

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Sponsor : Chia Nan University of Pharmacy and Science

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Tiss'You srl

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Tiss'You srl

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          August 02, 2023

                          Lead Product(s) : Collagen

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Florida State University

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Florida State University

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          March 02, 2023

                          Lead Product(s) : Collagen

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Sponsor : Tessenderlo Chemie NV

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          NovoBliss Research

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          NovoBliss Research

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          November 14, 2022

                          Lead Product(s) : Collagen

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Sponsor : Collagen Lifesciences Private Limited

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Rousselot BVBA

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Rousselot BVBA

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          February 23, 2022

                          Lead Product(s) : Collagen

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : BioTeSys GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          TCI Co., Ltd.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          TCI Co., Ltd.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          January 10, 2022

                          Lead Product(s) : Collagen

                          Therapeutic Area : Sleep

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          TCI Co., Ltd.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          TCI Co., Ltd.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          August 09, 2021

                          Lead Product(s) : Collagen

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          VIST

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          VIST

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          August 03, 2021

                          Lead Product(s) : Collagen

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Sponsor : Tosla d.o.o. | Slovenian Research Agency

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank